Answers are grounded in this paper and cite their sources.
Large-scale analysis reveals barriers and strategies in the field of stimuli-responsive therapeutics, indicating pathways for improvement.
We present a large-scale scientometric (pre-)clinical landscape analysis of stimuli-responsive therapeutics, highlighting the impact of nano-/micro-scale material platforms, and mapping translational barriers and strategies to overcome them.
No takes yet. Share an insight, caveat, or question.
Kobzev et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: